2Yavuz S, Paydas S, Disel U, et al. IDA -FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience[J]. Am J Ther, 2006,13: 389-393.
3Hashmi KU, Khan B, Ahmed P, et al. FLAG-IDA in the treatment of refractory / relapsed acute leukaemias~ single centre study[J]. J Pak Med Assoc, 2005,55:234-238.
4Montesinos P, Rubia Jdi, Orti G, et al. FLAG-IDA regimen ( fludarabine, eytarabine, idarubicin and G-CSF) in the treatment of patients with high2risk acute myeloid leukemia and myelodysp lastic syndromes[J]. Blood (ASH Annual Meeting Abstracts ) , 2007,110,2866.
6Specchia G, Pastore D, Carluccio P, et al. FLAG -IDA in the treatment of refractory/relapsed adult acute lymphoblastic leukemia[J]. Ann Hematol, 2005, 84 (12) :792-795.
2Jackson G, Taylor P, Smith GM, et al. A multicentre, open, noncomparative phase Ⅱ study of a combination of fludarabine phosphate, cytarabine and granulocyte colony-stimulating factor in relapsed and refractory acute myeloid leukemia and de novo refractory anemia with excess blasts in transformation. Br J Haematol,2001 ; 112 : 127 - 137
3Higashi Y, Turzanski J, Pallis M, et al. Contrasting in vitro effects for the combination of fludarabine, cytosine arabinoside (Ara-C) and granulocyte colony-stimulating factor (FLAG) compared with daunorubicin and Ara-C in P-glycoprotein-positive and P-glycoprotein-negative acute myeloblastic lenkaemia. Br J Haematol, 2000 ; 111:565 - 569
4Fleischhack G, Graf N, Hasan C, et al. IDA-FLAG ( idarubicin, fludarabine, high dosage cytarabine and G-CSF )-an effective therapy regimen in treatment of recurrent acute myelocytic leukemia in children and adolescents. Initial results of a pilot study. Klin Padiatr, 1996 ;208:229 - 235
5Yalman N, Sarper N, Devecioglu O, et al. Fludarabine, cytarabine, G-CSF and idarubicin (FLAG-IDA) for the treatment of relapsed or poor risk childhood acute leukemia. Turk J Pediatr, 2000 ;42 : 198 - 204
6Yavuz S, Paydas S, Disel U, et al. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a singlecenter experience. Am J Ther, 2006 ;13:389 -393
7Hashrni KU, Khan B, Ahmed P, et al. FLAG-IDA in the treatment of refractory/relapsed acute leukaemias: single centre study. J Pak Med Assoc, 2005;55:234 -238
8Montesinos P, Rubia Jdl, Orti G, et al. FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk acute myeloid leukemia and myelodysplastic syndromes. Blood (ASH Annual Meeting Abstracts ), 2007;110:2866
